SCHEMBL20312352

SCHEMBL20312352

CCOB(OCC)c1ccccc1N(C)C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.34
GAA P10253 2/20 0.34
ALDH1A1 P00352 2/20 0.34
TP53 P04637 1/20 0.34
TSHR P16473 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
KDM4E B2RXH2 1/20 0.33
CHEK1 O14757 1/20 0.33
NEK2 P51955 1/20 0.33
LIMK1 P53667 1/20 0.33
DYRK1A Q13627 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33
LIPG Q9Y5X9 1/20 0.31
HTR6 P50406 1/20 0.31
KMT2A Q03164 1/20 0.31
NSD2 O96028 1/20 0.31
EGFR P00533 1/20 0.31
LMNA P02545 1/20 0.31
MAPK1 P28482 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20312337 0.78 MAPT (0.38) MAPTGAAALDH1A1TP53TSHR
SCHEMBL20312281 0.74 MAPT (0.38) MAPTGAAALDH1A1TP53TSHR
SCHEMBL22000805 0.74 TSHR (0.38) MAPTGAAALDH1A1TSHRKMT2A
SCHEMBL20312369 0.73 MAPT (0.34) MAPTGAAALDH1A1TP53TSHR
SCHEMBL20312338 0.72 ALDH1A1 (0.45) MAPTGAAALDH1A1TP53TSHR
SCHEMBL28980697 0.72 L3MBTL1 (0.40) MAPTGAAALDH1A1TSHRKDM4E
SCHEMBL21567696 0.71 ENPP2 (0.55) MAPTALDH1A1TP53TSHRKMT2A
SCHEMBL27870 0.70 MAPT (0.46) MAPTGAAALDH1A1TP53TSHR
SCHEMBL20312265 0.70 MAPT (0.41) MAPTGAAALDH1A1TP53TSHR
SCHEMBL29589969 0.70 MAPT (0.46) MAPTGAAALDH1A1TP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10504732-B2 Impurity diffusion agent composition and method for manufacturing semiconductor substrate TOKYO OHKA KOGYO CO, LTD. (JP) 2019-12-10 US disclosed
US-20180182624-A1 IMPURITY DIFFUSION AGENT COMPOSITION AND METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE TOKYO OHKA KOGYO CO., LTD. (JP) 2018-06-28 US disclosed
US-20180182624-A1 IMPURITY DIFFUSION AGENT COMPOSITION AND METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE TOKYO OHKA KOGYO CO., LTD. (JP) 2018-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180182624-A1 IMPURITY DIFFUSION AGENT COMPOSITION AND METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE SLC43A1, SAMHD1, SNRPD2 MAPT 1110/4885GAA 730/4885ALDH1A1 2704/4885
US-10504732-B2 Impurity diffusion agent composition and method for manufacturing semiconductor substrate SLC43A1, SAMHD1, SNRPD2 MAPT 1110/4885GAA 730/4885ALDH1A1 2704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.